Comorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study
The Journal of Clinical Endocrinology & Metabolism · 17.11.2023 · 108 (12) · e1695-e1701
DOI: 10.1210/clinem/dgad334 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 06.06.2023. Verfasst von Emmi Danner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: Congenital Hypothyroidism. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Pediatric Research, Kuopio University Hospital.
Abstract (Originalsprache)
Context
Patients with congenital hypothyroidism (CH) are affected more often than the general population by other chronic diseases and neurological difficulties.
Objective
The aim of this nationwide population-based register study was to investigate the incidence of congenital malformations, comorbidities, and the use of prescribed drugs in patients with primary CH.
Methods
The study cohort and matched controls were identified from national population-based registers in Finland. All diagnoses from birth until the end of 2018 were collected from the Care Register, and subject-specific prescription drug purchases were identified from The Prescription Register from birth until the end of 2017.
Results
Diagnoses of neonatal and chronic diseases were collected for 438 full-term patients and 835 controls (median follow-up time 11.6 years; range, 0-23 years). Newborns with CH were more often found to have neonatal jaundice (11.2% and 2.0%; P < .001), hypoglycemia (8.9% and 2.8%; P < .001), metabolic acidemia (3.2% and 1.1%; P = .007), and respiratory distress (3.9% and 1.3%; P < .003) as compared to their matched controls. Congenital malformations were diagnosed in 66 of 438 (15.1%) CH patients and in 62 of 835 (7.4%) controls (P < .001). The most commonly affected extrathyroidal systems were the circulatory and musculoskeletal systems. The cumulative incidence of hearing loss and specific developmental disorders was higher among CH patients than controls. The use of antidepressant and antipsychotic drugs was similar in CH patients and their controls.
Conclusion
CH patients have more neonatal morbidity and congenital malformations than their matched controls. The cumulative incidence of neurological disorders is higher in CH patients. However, our results do not support the existence of severe psychiatric comorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
- Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
- School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
ORCID-Profile: Emmi Danner
Förderung
- Foundation for Pediatric Research
- Kuopio University Hospital
Zitieren
APA
Danner, E., Jääskeläinen, J., Niuro, L., Huopio, H., Niinikoski, H., Viikari, L., Kero, J., & Sund, R. (2023). Comorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study. The Journal of Clinical Endocrinology & Metabolism, 108(12), e1695-e1701. https://doi.org/10.1210/clinem/dgad334
Vancouver
Danner E, Jääskeläinen J, Niuro L, Huopio H, Niinikoski H, Viikari L, et al. Comorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2023;108(12):e1695-e1701. doi:10.1210/clinem/dgad334
BibTeX
@article{Danner2023,
author = {Danner, Emmi and Jääskeläinen, Jarmo and Niuro, Laura and Huopio, Hanna and Niinikoski, Harri and Viikari, Liisa and Kero, Jukka and Sund, Reijo},
title = {Comorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {12},
pages = {e1695--e1701},
doi = {10.1210/clinem/dgad334}
}
EUVIMED